Research Studies

Study Title

Cytokinetics VITALITY Trial (Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year)

Enrollment Status

Completed

Principal Investigators

Site-PI: Michael Benatar, MD, PhD

Study Type

Drug Trial

Goals

To assessed the effect of tirasemtiv versus placebo on respiratory function in patients with ALS.

Enrolling

ALS patients

Eligibility

Click to Expand

Study Involvement

Click to Expand

Contact

Links

Primary Funding Source

Cytokinetics

Related Publications

Click to Expand

Shefner JM, Cudkowicz ME, Hardiman O, Cockcroft BM, Lee JH, Malik FI, Meng L, Rudnicki SA, Wolff AA, Andrews JA; VITALITY-ALS Study Group. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;0(0):1-11.

https://pubmed.ncbi.nlm.nih.gov/31081694

Related Presentations & Lectures

Click to Expand

No items found